Kaneva Tablet 150 mg contains Erlotinib, a targeted anticancer medication widely used in the treatment of certain solid tumors, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib is classified as a tyrosine kinase inhibitor (TKI) and works by selectively blocking cancer cell growth pathways, offering a more focused approach compared to conventional chemotherapy.

The 150 mg strength represents the commonly recommended standard dose for many adult patients, especially in EGFR-positive lung cancer, as determined by an oncologist based on individual patient needs and treatment response.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Mechanism of Action

Erlotinib acts by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, a protein that plays a critical role in the growth and survival of cancer cells. Overexpression or mutation of EGFR is commonly seen in certain cancers and contributes to:

• Rapid cancer cell proliferation

• Tumor growth and spread

• Resistance to normal cell death

By blocking EGFR signaling, Kaneva Tablet:

• Suppresses cancer cell multiplication

• Induces apoptosis in malignant cells

• Helps control disease progression

This targeted mechanism allows for effective cancer control with reduced impact on normal cells.

Therapeutic Indications

Kaneva Tablet 150 mg is indicated for:

• Non-small cell lung cancer (NSCLC) with confirmed EGFR mutations

• Locally advanced or metastatic lung cancer after failure of prior chemotherapy

• Advanced pancreatic cancer, usually in combination with other anticancer treatments

The medicine is prescribed as part of an individualized oncology treatment plan.

Dosage and Administration

• Kaneva Tablet should be taken only under the supervision of a cancer specialist.

• The usual dose is 150 mg once daily, or as prescribed by the physician.

• It should be taken on an empty stomach, at least 1 hour before or 2 hours after food.

• Tablets must be swallowed whole with water and should not be crushed or chewed.

Consistency in dosing and timing is essential to ensure maximum therapeutic benefit.

Safety and Precautions

• Not recommended for use without medical supervision.

• Use cautiously in patients with liver disease, lung disorders, or gastrointestinal conditions.

• Smoking can significantly reduce the effectiveness of Erlotinib and should be avoided.

• Regular clinical monitoring, including liver function tests, may be required during treatment.

Patients should inform their doctor about all medications and supplements they are taking to avoid potential interactions.

Possible Side Effects

Some patients may experience side effects, which can vary in severity. Commonly reported effects include:

• Skin rash or acne-like eruptions

• Diarrhea

• Fatigue

• Loss of appetite

Most side effects are manageable with appropriate medical care, and dose adjustment may be considered if necessary.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store below 30°C in a dry place.

• Protect from moisture and direct sunlight.

• Keep out of reach of children.

Key Benefits

• Standard high-dose targeted therapy option

• Effective EGFR inhibition in cancer cells

• Oral formulation for convenient administration

• Plays a vital role in modern cancer management

Kaneva Tablet 150 mg (Erlotinib) offers a targeted and effective treatment approach for eligible cancer patients, helping control disease progression and improve treatment outcomes when used under expert medical guidance.